XML 46 R28.htm IDEA: XBRL DOCUMENT v3.25.3
REVENUE RECOGNITION AND RELATED ALLOWANCES (Tables)
 9 Months Ended
Sep. 30, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of disaggregation of revenue and revenue recognized
All revenue recognized in the accompanying unaudited condensed consolidated statements of operations is considered to be revenue from contracts with customers. The following table depicts the disaggregation of revenue:
Three Months Ended September 30,Nine Months Ended September 30,
Products and Services (in thousands)2025202420252024
Rare Disease and Brands
Cortrophin Gel$101,850 $52,555 $236,347 $138,685 
ILUVIEN and YUTIQ16,600 3,871 55,025 3,871 
Rare Disease total net revenues$118,450 $56,426 $291,372 $142,556 
Brands10,675 9,195 48,993 44,900 
Rare Disease and Brands total net revenues$129,125 $65,621 $340,365 $187,456 
Generics and Other
Generic pharmaceutical products$94,375 $78,223 $283,350 $222,404 
Royalties and other pharmaceutical services4,313 4,488 12,591 13,942 
Generics and Other total net revenues98,688 82,711 295,941 236,346 
Total net revenues$227,813 $148,332 $636,306 $423,802 
Schedule of accruals and allowances
The following table summarizes activity in the unaudited condensed consolidated balance sheets for accruals and allowances for the nine months ended September 30, 2025 and 2024, respectively:
Accruals for Chargebacks, Returns, and Other Allowances
(in thousands)ChargebacksGovernment
Rebates		ReturnsAdministrative
Fees and Other
Rebates		Prompt
Payment
Discounts
Balance at December 31, 2023$84,208 $12,168 $29,678 $11,412 $4,865 
Impact of Alimera acquisition95 — 3,095 671 — 
Accruals/Adjustments403,201 19,757 28,737 44,622 17,159 
Credits Taken Against Reserve(410,508)(21,232)(24,442)(43,486)(17,218)
Balance at September 30, 2024 (1)$76,996 $10,693 $37,068 $13,219 $4,806 
Balance at December 31, 2024$105,630 $18,714 $39,274 $19,588 $6,258 
Accruals/Adjustments493,008 53,983 30,977 62,159 26,199 
Credits Taken Against Reserve(496,765)(35,665)(20,246)(58,645)(25,495)
Balance at September 30, 2025 (1)$101,873 $37,032 $50,005 $23,102 $6,962 
______________________________________________
(1)Chargebacks are included as an offset to accounts receivable, net of chargebacks and other allowances in the unaudited condensed consolidated balance sheets. Administrative Fees and Other Rebates and Prompt Payment Discounts are included as a reduction to accounts receivable, net of chargebacks and other allowances or accrued expenses and other in the unaudited condensed consolidated balance sheets. Returns are included in returned goods reserve in the unaudited condensed consolidated balance sheets. Government Rebates are included in accrued government rebates in the unaudited condensed consolidated balance sheets.
Schedule of customer concentration
The four customers represent the total percentage of net revenues as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Customer 113 %20 %19 %26 %
Customer 27 %10 %9 %12 %
Customer 317 %14 %14 %12 %
Customer 426 %17 %21 %15 %